期刊文献+

脐带Wharton胶来源MSCs生物学特性及其优越性的研究进展 被引量:7

RESEARCH PROGRESS OF BIOLOGICAL CHARACTERISTICS AND ADVANTAGES OF WHARTON'S JELLY-MESENCHYMAL STEM CELLS
原文传递
导出
摘要 目的总结脐带Wharton胶来源MSCs(Wharton’s jelly-MSCs,WJ-MSCs)生物学特性及其优越性的研究进展。方法查阅近年来关于WJ-MSCs的生物学特性及其与脐带血MSCs(umbilical cord blood MSCs,UBMSCs)和BMSCs相比较的文献,进行综述分析。结果从脐带Wharton胶中可分离获得大量具有自我复制、自我更新、高度增殖和多向分化潜能的MSCs。与UBMSCs和BMSCs相比较,WJ-MSCs在分离时间、分离成功率、倍增时间、传代数量和扩增潜能等方面均具有优越性。结论 WJ-MSCs具有取材简便、来源丰富、相对纯净、无伦理问题等优点,是细胞移植治疗、基因治疗和组织工程器官构建的理想种子细胞,为组织再生修复与原位重建提供了新思路。 Objective To summarize the research progress of biological characteristics and advantages of Wharton’sjelly-mesenchymal stem cells(WJ-MSCs).Methods The related literature on the biological characteristics of WJ-MSCs,umbilical cord blood MSCs(UBMSCs) and bone marrow MSCs(BMSCs) was extensively reviewed and analyzed.Results A large number of MSCs which are able to self-replicate,self-renew and have high proliferation and multipotent differentiation can be isolated from the Wharton’s jelly of umbilical cord.WJ-MSCs have many advantages in isolation time,isolation efficience,expansion time,passage capacity,expansion capacity when compared with UBMSCs and BMSCs.Conclusion WJ-MSCs have numerous advantages of convenient and abundant sources,relatively pure,non-ethical issues,and so on,which can be used for cell transplant therapy,gene therapy,and the ideal seed cells of building tissue engineered organ,so they provide new ideas for tissue regeneration repair and reconstruction.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2011年第6期745-749,共5页 Chinese Journal of Reparative and Reconstructive Surgery
基金 卫生公益性行业科研专项资助项目(200802066)~~
关键词 Wharton胶来源MSCs 生物学特性 诱导分化 脐带血MSCs BMSCS Wharton's jelly-mesenchymal stem cells Biological characteristic Differentiation Umbilical cord blood mesenchymal stem cells Bone marrow mesenchymal stem cells
  • 相关文献

参考文献49

  • 1Nekanti U, Rao VB, Bahirvani AG, et al. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesen- chymal stem cells. Stem Cells Dev, 2010, 19(1): 117-130.
  • 2Anzalone R, Iacono ML, Corrao S, et al. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev, 2010, 19(4): 423-438.
  • 3Karahuseyinoglu S, Cinar O, Kilic E, et al. Biology of the stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells, 2007, 25(2): 319-331.
  • 4Mitchel KE, Weiss ML, Mitchell BM, et al. Matrix cells from Wharton's jelly from neurons and gl ia. Stem Cells, 2005, 21 (1): 50-60.
  • 5Lu LL, Liu YJ,Yang SG, et al. Isolation and characterization of hu- man umbilical cord mesenchymal stem cells with hematopoiesis- supportive function and other potentials. Haematologica, 2006, 91(8): 1017-1026.
  • 6Carlin R, Davis D, Weiss M, et al. Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) ma- trix cells. Reprod Biol Endocrinol, 2006, 4: 8-21.
  • 7Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 2004, 22(7): 1330-1337.
  • 8Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord ma- trix stem ceils: preliminary characterization and effect of transplanta- tion in a rodent model of Parldnson's disease. Stem Cells, 2006, 24(3): 781-792.
  • 9Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells, 2008, 26(3): 591-599.
  • 10Bakhshi T, Zabriskie RC, Bodie S, et al. Mesenchymal stem ceils from the Wharton's jelly of umbilical cord segments provide stromal sup- port for the maintenance of cord blood hematopoietic stern cells dur- ing long-term ex vivo culture. Transfusion, 2008, 48(12): 2638-2644.

二级参考文献28

共引文献29

同被引文献103

  • 1蒲志超,谢伟勇,王延斌,薛剑,张兴世.骨形态发生蛋白7腺病毒基因转染对骨髓基质干细胞生物学功能的影响[J].中国组织工程研究,2015,19(6):837-842. 被引量:4
  • 2韩操,马宁,李忠义,王正东,颜南,朱世龙.自体骨髓间充质干细胞载体复合物修复骨缺损的组织学观察[J].中国组织工程研究,2015,19(6):891-897. 被引量:6
  • 3中华人民共和国科学技术部.关于善待实验动物的指导性意见[S].2006.9.
  • 4Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton' s jelly of the human umbilical cord[J]. Stem Cells, 2004,22 (7) : 1330-1337.
  • 5Wu KH, Mo XM, Zhou B, et al. Cardiac potential of stem cells from whole human umbilical cord tissue [ J ]. J Cell Biochem, 2009,107 (5) :926-932.
  • 6Latifpour M, Nematollahi-Mahani SN, Deilamy M, et al. Improve-ment in cardiac function following transplantation of human umbili- ca] cord matrix-derived mesenehyma] cells[J]. Cardiology,2011, 120(1) :9-18.
  • 7Kahan BD. Fifty years in the vineyard of transplantation: Looking back[J]. Transplant Proc, 2011,43(8) :2853-2859.
  • 8Jessup M, Brozena S. Heart failure[ J]. N Engl J Med, 2003,348 ( 20 ) .. 2007 -2018.
  • 9Terzic A, Nelson TJ. Regenerative medicine advancing health care 2020 [ J]. J Am Coil Cardiol, 2010,55 (20) :2254-2257.
  • 10Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects[ J]. Ann Thorac Surg, 2002,73 (6) : 1919- 1925.

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部